{"id":1058124,"date":"2021-01-22T09:18:03","date_gmt":"2021-01-22T08:18:03","guid":{"rendered":"https:\/\/frezzapartners.com\/?p=1058124"},"modified":"2021-01-22T09:18:03","modified_gmt":"2021-01-22T08:18:03","slug":"disturbi-neurologici-accordo-di-partnership-servier-mina-therapeutics","status":"publish","type":"post","link":"https:\/\/frezzapartners.com\/en\/disturbi-neurologici-accordo-di-partnership-servier-mina-therapeutics\/","title":{"rendered":"Disturbi neurologici, accordo di partnership Servier-MiNA Therapeutics"},"content":{"rendered":"<p>photo by <span class=\"attribution_field hide-sm hide-md\">chiplanay<\/span><\/p>\n<p>&nbsp;<\/p>\n<p>Servier e MiNA Therapeutics, pioniere delle terapie per l&#8217;attivazione dell&#8217;RNA, hanno annunciato una partnership di ricerca per identificare e sviluppare terapie con piccoli RNA attivanti (saRNA) per il trattamento dei disturbi neurologici.<\/p>\n<p>MiNA Therapeutics utilizzer\u00e0 la sua piattaforma saRNA per identificare nuovi potenziali trattamenti per ripristinare la normale funzione cellulare nei disturbi neurologici. Servier sar\u00e0 responsabile dello sviluppo preclinico e clinico dei candidati principali e avr\u00e0 i diritti per la commercializzazione di qualsiasi prodotto derivante dalla collaborazione.<\/p>\n<p>&#8220;L&#8217;approccio innovativo di MiNA per attivare l&#8217;espressione genica attraverso piccoli RNA attivanti \u00e8 un&#8217;opportunit\u00e0 entusiasmante per sbloccare il potenziale per il trattamento di malattie neurodegenerative geneticamente definite, per le quali ci sono attualmente opzioni di trattamento limitate&#8221;, ha commentato Ross Jeggo, capo del Servier Neurology and Immuno- Area terapeutica antinfiammatoria.<\/p>\n<p>&#8220;Siamo lieti di dare il benvenuto al team MiNA e di combinare il loro approccio unico al ripristino della funzione cellulare con l&#8217;attenzione di Servier sul trattamento delle malattie neurologiche&#8221;.<\/p>\n<p>fonte: <a href=\"https:\/\/servier.com\/en\/news\/neurological-diseases-servier-partners-with-mina-therapeutics\/\">Servier<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>photo by chiplanay &nbsp; Servier e MiNA Therapeutics, pioniere delle terapie per l&#8217;attivazione dell&#8217;RNA, hanno annunciato una partnership di ricerca per identificare e sviluppare terapie con piccoli RNA attivanti (saRNA) per il trattamento dei disturbi neurologici. MiNA Therapeutics utilizzer\u00e0 la sua piattaforma saRNA per identificare nuovi potenziali trattamenti per ripristinare la normale funzione cellulare nei disturbi neurologici. Servier sar\u00e0 responsabile dello sviluppo preclinico e clinico dei candidati principali e avr\u00e0 i diritti per la commercializzazione di qualsiasi prodotto derivante dalla&#8230;<\/p>\n","protected":false},"author":297440,"featured_media":1058125,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[141],"tags":[3038,2774],"class_list":["post-1058124","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-mina-therapeutics","tag-servier"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Disturbi neurologici, accordo di partnership Servier-MiNA Therapeutics - Frezza Partners<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/frezzapartners.com\/disturbi-neurologici-accordo-di-partnership-servier-mina-therapeutics\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Disturbi neurologici, accordo di partnership Servier-MiNA Therapeutics - Frezza Partners\" \/>\n<meta property=\"og:description\" content=\"photo by chiplanay &nbsp; Servier e MiNA Therapeutics, pioniere delle terapie per l&#8217;attivazione dell&#8217;RNA, hanno annunciato una partnership di ricerca per identificare e sviluppare terapie con piccoli RNA attivanti (saRNA) per il trattamento dei disturbi neurologici. MiNA Therapeutics utilizzer\u00e0 la sua piattaforma saRNA per identificare nuovi potenziali trattamenti per ripristinare la normale funzione cellulare nei disturbi neurologici. Servier sar\u00e0 responsabile dello sviluppo preclinico e clinico dei candidati principali e avr\u00e0 i diritti per la commercializzazione di qualsiasi prodotto derivante dalla...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/frezzapartners.com\/disturbi-neurologici-accordo-di-partnership-servier-mina-therapeutics\/\" \/>\n<meta property=\"og:site_name\" content=\"Frezza Partners\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-22T08:18:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/frezzapartners.com\/wp-content\/uploads\/2021\/01\/human-5075068_1920.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"960\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Frezza Partners\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Frezza Partners\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/disturbi-neurologici-accordo-di-partnership-servier-mina-therapeutics\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/disturbi-neurologici-accordo-di-partnership-servier-mina-therapeutics\\\/\"},\"author\":{\"name\":\"Frezza Partners\",\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/#\\\/schema\\\/person\\\/b953d1492c9f06a9923aed3b3cbe9fc0\"},\"headline\":\"Disturbi neurologici, accordo di partnership Servier-MiNA Therapeutics\",\"datePublished\":\"2021-01-22T08:18:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/disturbi-neurologici-accordo-di-partnership-servier-mina-therapeutics\\\/\"},\"wordCount\":175,\"image\":{\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/disturbi-neurologici-accordo-di-partnership-servier-mina-therapeutics\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/frezzapartners.com\\\/wp-content\\\/uploads\\\/2021\\\/01\\\/human-5075068_1920.jpg\",\"keywords\":[\"mina therapeutics\",\"servier\"],\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/disturbi-neurologici-accordo-di-partnership-servier-mina-therapeutics\\\/\",\"url\":\"https:\\\/\\\/frezzapartners.com\\\/disturbi-neurologici-accordo-di-partnership-servier-mina-therapeutics\\\/\",\"name\":\"Disturbi neurologici, accordo di partnership Servier-MiNA Therapeutics - Frezza Partners\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/disturbi-neurologici-accordo-di-partnership-servier-mina-therapeutics\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/disturbi-neurologici-accordo-di-partnership-servier-mina-therapeutics\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/frezzapartners.com\\\/wp-content\\\/uploads\\\/2021\\\/01\\\/human-5075068_1920.jpg\",\"datePublished\":\"2021-01-22T08:18:03+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/#\\\/schema\\\/person\\\/b953d1492c9f06a9923aed3b3cbe9fc0\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/disturbi-neurologici-accordo-di-partnership-servier-mina-therapeutics\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/frezzapartners.com\\\/disturbi-neurologici-accordo-di-partnership-servier-mina-therapeutics\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/disturbi-neurologici-accordo-di-partnership-servier-mina-therapeutics\\\/#primaryimage\",\"url\":\"https:\\\/\\\/frezzapartners.com\\\/wp-content\\\/uploads\\\/2021\\\/01\\\/human-5075068_1920.jpg\",\"contentUrl\":\"https:\\\/\\\/frezzapartners.com\\\/wp-content\\\/uploads\\\/2021\\\/01\\\/human-5075068_1920.jpg\",\"width\":1920,\"height\":960},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/disturbi-neurologici-accordo-di-partnership-servier-mina-therapeutics\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/frezzapartners.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Disturbi neurologici, accordo di partnership Servier-MiNA Therapeutics\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/#website\",\"url\":\"https:\\\/\\\/frezzapartners.com\\\/\",\"name\":\"Frezza Partners\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/frezzapartners.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/frezzapartners.com\\\/#\\\/schema\\\/person\\\/b953d1492c9f06a9923aed3b3cbe9fc0\",\"name\":\"Frezza Partners\",\"url\":\"https:\\\/\\\/frezzapartners.com\\\/en\\\/author\\\/fr3zz4partn3rs\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Disturbi neurologici, accordo di partnership Servier-MiNA Therapeutics - Frezza Partners","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/frezzapartners.com\/disturbi-neurologici-accordo-di-partnership-servier-mina-therapeutics\/","og_locale":"en_US","og_type":"article","og_title":"Disturbi neurologici, accordo di partnership Servier-MiNA Therapeutics - Frezza Partners","og_description":"photo by chiplanay &nbsp; Servier e MiNA Therapeutics, pioniere delle terapie per l&#8217;attivazione dell&#8217;RNA, hanno annunciato una partnership di ricerca per identificare e sviluppare terapie con piccoli RNA attivanti (saRNA) per il trattamento dei disturbi neurologici. MiNA Therapeutics utilizzer\u00e0 la sua piattaforma saRNA per identificare nuovi potenziali trattamenti per ripristinare la normale funzione cellulare nei disturbi neurologici. Servier sar\u00e0 responsabile dello sviluppo preclinico e clinico dei candidati principali e avr\u00e0 i diritti per la commercializzazione di qualsiasi prodotto derivante dalla...","og_url":"https:\/\/frezzapartners.com\/disturbi-neurologici-accordo-di-partnership-servier-mina-therapeutics\/","og_site_name":"Frezza Partners","article_published_time":"2021-01-22T08:18:03+00:00","og_image":[{"width":1920,"height":960,"url":"https:\/\/frezzapartners.com\/wp-content\/uploads\/2021\/01\/human-5075068_1920.jpg","type":"image\/jpeg"}],"author":"Frezza Partners","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Frezza Partners","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/frezzapartners.com\/disturbi-neurologici-accordo-di-partnership-servier-mina-therapeutics\/#article","isPartOf":{"@id":"https:\/\/frezzapartners.com\/disturbi-neurologici-accordo-di-partnership-servier-mina-therapeutics\/"},"author":{"name":"Frezza Partners","@id":"https:\/\/frezzapartners.com\/#\/schema\/person\/b953d1492c9f06a9923aed3b3cbe9fc0"},"headline":"Disturbi neurologici, accordo di partnership Servier-MiNA Therapeutics","datePublished":"2021-01-22T08:18:03+00:00","mainEntityOfPage":{"@id":"https:\/\/frezzapartners.com\/disturbi-neurologici-accordo-di-partnership-servier-mina-therapeutics\/"},"wordCount":175,"image":{"@id":"https:\/\/frezzapartners.com\/disturbi-neurologici-accordo-di-partnership-servier-mina-therapeutics\/#primaryimage"},"thumbnailUrl":"https:\/\/frezzapartners.com\/wp-content\/uploads\/2021\/01\/human-5075068_1920.jpg","keywords":["mina therapeutics","servier"],"articleSection":["News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/frezzapartners.com\/disturbi-neurologici-accordo-di-partnership-servier-mina-therapeutics\/","url":"https:\/\/frezzapartners.com\/disturbi-neurologici-accordo-di-partnership-servier-mina-therapeutics\/","name":"Disturbi neurologici, accordo di partnership Servier-MiNA Therapeutics - Frezza Partners","isPartOf":{"@id":"https:\/\/frezzapartners.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/frezzapartners.com\/disturbi-neurologici-accordo-di-partnership-servier-mina-therapeutics\/#primaryimage"},"image":{"@id":"https:\/\/frezzapartners.com\/disturbi-neurologici-accordo-di-partnership-servier-mina-therapeutics\/#primaryimage"},"thumbnailUrl":"https:\/\/frezzapartners.com\/wp-content\/uploads\/2021\/01\/human-5075068_1920.jpg","datePublished":"2021-01-22T08:18:03+00:00","author":{"@id":"https:\/\/frezzapartners.com\/#\/schema\/person\/b953d1492c9f06a9923aed3b3cbe9fc0"},"breadcrumb":{"@id":"https:\/\/frezzapartners.com\/disturbi-neurologici-accordo-di-partnership-servier-mina-therapeutics\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/frezzapartners.com\/disturbi-neurologici-accordo-di-partnership-servier-mina-therapeutics\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/frezzapartners.com\/disturbi-neurologici-accordo-di-partnership-servier-mina-therapeutics\/#primaryimage","url":"https:\/\/frezzapartners.com\/wp-content\/uploads\/2021\/01\/human-5075068_1920.jpg","contentUrl":"https:\/\/frezzapartners.com\/wp-content\/uploads\/2021\/01\/human-5075068_1920.jpg","width":1920,"height":960},{"@type":"BreadcrumbList","@id":"https:\/\/frezzapartners.com\/disturbi-neurologici-accordo-di-partnership-servier-mina-therapeutics\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/frezzapartners.com\/"},{"@type":"ListItem","position":2,"name":"Disturbi neurologici, accordo di partnership Servier-MiNA Therapeutics"}]},{"@type":"WebSite","@id":"https:\/\/frezzapartners.com\/#website","url":"https:\/\/frezzapartners.com\/","name":"Frezza Partners","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/frezzapartners.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/frezzapartners.com\/#\/schema\/person\/b953d1492c9f06a9923aed3b3cbe9fc0","name":"Frezza Partners","url":"https:\/\/frezzapartners.com\/en\/author\/fr3zz4partn3rs\/"}]}},"_links":{"self":[{"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/posts\/1058124","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/users\/297440"}],"replies":[{"embeddable":true,"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/comments?post=1058124"}],"version-history":[{"count":0,"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/posts\/1058124\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/media\/1058125"}],"wp:attachment":[{"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/media?parent=1058124"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/categories?post=1058124"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/frezzapartners.com\/en\/wp-json\/wp\/v2\/tags?post=1058124"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}